219 related articles for article (PubMed ID: 24480551)
1. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
Shoji H; Shirakura T; Fukuchi K; Takuma T; Hanaki H; Tanaka K; Niki Y
J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
[TBL] [Abstract][Full Text] [Related]
3. GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis.
Kondo H; Ito S; Hatazaki K; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M; Deguchi T
J Infect Chemother; 2018 Mar; 24(3):232-235. PubMed ID: 29138021
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU.
Liu YH; Kuo SC; Lee YT; Chang IC; Yang SP; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):108-12. PubMed ID: 22153765
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD
J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
[TBL] [Abstract][Full Text] [Related]
7. Emergence of Haemophilus influenzae with low susceptibility to quinolones isolated from pediatric patients in Japan.
Takeuchi N; Ohkusu M; Hoshino T; Yamamoto S; Segawa S; Murata S; Ishiwada N
J Infect Chemother; 2021 Jul; 27(7):1020-1026. PubMed ID: 33658143
[TBL] [Abstract][Full Text] [Related]
8. Activities and postantibiotic effects of gemifloxacin compared to those of 11 other agents against Haemophilus influenzae and Moraxella catarrhalis.
Davies TA; Kelly LM; Hoellman DB; Ednie LM; Clark CL; Bajaksouzian S; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Mar; 44(3):633-9. PubMed ID: 10681330
[TBL] [Abstract][Full Text] [Related]
9. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
J Clin Microbiol; 2004 Mar; 42(3):1185-91. PubMed ID: 15004073
[TBL] [Abstract][Full Text] [Related]
10. Microbial virulence, molecular epidemiology and pathogenic factors of fluoroquinolone-resistant Haemophilus influenzae infections in Guangzhou, China.
Chen D; Wen S; Feng D; Xu R; Liu J; Peters BM; Su D; Lin Y; Yang L; Xu Z; Shirtliff ME
Ann Clin Microbiol Antimicrob; 2018 Nov; 17(1):41. PubMed ID: 30470228
[TBL] [Abstract][Full Text] [Related]
11. Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.
Tanaka E; Wajima T; Noguchi N
J Med Microbiol; 2019 Aug; 68(8):1227-1232. PubMed ID: 31215858
[TBL] [Abstract][Full Text] [Related]
12. Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus revealed through a horizontal transfer assay using Haemophilus influenzae.
Tanaka E; Wajima T; Nakaminami H; Uchiya KI
J Antimicrob Chemother; 2023 May; 78(5):1225-1230. PubMed ID: 36949027
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
14. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
[TBL] [Abstract][Full Text] [Related]
15. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels.
Alcaide E; Blasco MD; Esteve C
Res Microbiol; 2010; 161(1):40-5. PubMed ID: 19900538
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance in Haemophilus influenzae from nursing home residents in Taiwan: correlation of MICs and mutations in QRDRs.
Chang CM; Shih HI; Wu CJ; Lauderdale TL; Lee NY; Lee CC; Chen YC; Huang CC; Ko WC
J Appl Microbiol; 2020 Jun; 128(6):1624-1633. PubMed ID: 31951091
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.
Yoshizumi S; Takahashi Y; Watanabe Y; Okezaki E; Ishii Y; Tateda K
Chemotherapy; 2004 Dec; 50(6):265-75. PubMed ID: 15608441
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.
Eaves DJ; Randall L; Gray DT; Buckley A; Woodward MJ; White AP; Piddock LJ
Antimicrob Agents Chemother; 2004 Oct; 48(10):4012-5. PubMed ID: 15388468
[TBL] [Abstract][Full Text] [Related]
20. In vitro activities of garenoxacin (BMS-284756) against Haemophilus influenzae isolates with different fluoroquinolone susceptibilities.
Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
Antimicrob Agents Chemother; 2003 Nov; 47(11):3539-41. PubMed ID: 14576114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
